Interim effect evaluation of the hepatitis C elimination programme in Georgia: A modelling study
The Lancet Global Health Jan 31, 2020
Walker JG, et al. - Investigators designed a modelling study to investigate the interim effect of the programme and feasibility of achieving the elimination goal. A transmission model was developed to capture the hepatitis C epidemic in Georgia, calibrated to data from biobehavioural surveys of people who inject drugs (PWID; 1998–2015) and a national survey (2015). The impact was evaluated in terms of the relative reduction in hepatitis C incidence, prevalence, and mortality relative to 2015 and of the deaths and infections averted compared with a counterfactual of no treatment over the study period. Between May 1, 2015, and Feb 28, 2019, 54,313 individuals were treated, with about 1,000 individuals treated per month since mid-2017. The outcomes of this study demonstrated that Georgia's hepatitis C elimination programme has achieved substantial treatment scale-up, which has decreased the burden of chronic hepatitis C. Nevertheless, the country is incredible to meet its 2020 elimination target unless treatment scales up considerably.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries